Joanna L. Whitehouse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joanna L. Whitehouse has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Edward F. Nash
West Midlands Adult CF Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
5 shared publications - Alan Robert Smyth
School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, Northern Ireland, United Kingdom
4 shared publications - Miguel Cámara
National Biofilms Innovation Centre, Biodiscovery Institute, School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK
4 shared publications - Paul Williams
National Biofilms Innovation Centre, Biodiscovery Institute, School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK
4 shared publications - Alan J. Knox
Division of Respiratory Medicine, University of Nottingham, City Hospital Campus, Nottingham, UK
3 shared publications Andrew Fogarty
Division of Epidemiology and Public Health, Nottingham NIHR Biomedical Research Centre, University of Nottingham, City Hospital Campus, Nottingham, UK; Nottingham MRC Molecular Pathology Node, UK; UK NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK
3 shared publications
Latest Publications
- Open Access
- 6 July 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (6) , 1002-1009
Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis
- 6 July 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (6) , 1002-1009
Open AccessBody mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis
- 9 June 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22, S166-S167
P333 Refresh: patient experience of an online healthy eating webinar designed specifically for adults with cystic fibrosis on CFTR modulators
- 9 June 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22, S166-S167
P333 Refresh: patient experience of an online healthy eating webinar designed specifically for adults with cystic fibrosis on CFTR modulators
- Open Access
- 27 January 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (2) , 275-281
Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis
- 27 January 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (2) , 275-281
Open AccessDiabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis
- 1 July 2022
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 21 (4) , 626-629
Novel detection of specific bacterial quorum sensing molecules in saliva: Potential non-invasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis
- 1 July 2022
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 21 (4) , 626-629
Novel detection of specific bacterial quorum sensing molecules in saliva: Potential non-invasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis
- 16 May 2022
- Published by Elsevier in Respiratory Medicine
- Vol. 199, 106878
Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies
- 16 May 2022
- Published by Elsevier in Respiratory Medicine
- Vol. 199, 106878
Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies
- Open Access
- 3 February 2022
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 71 (2) , 001481
Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis
Although anaerobic bacteria exist in abundance in cystic fibrosis (CF) airways, their role in disease progression is poorly understood. We hypothesized that the presence and relative abundance of the most prevalent, live, anaerobic bacteria in sputum of adults with CF were associated with adverse clinical outcomes. This is the first study to prospectively investigate viable anaerobic bacteria present in the sputum microbiota and their relationship with long-term outcomes in adults with CF. We performed 16S rRNA analysis using a viability quantitative PCR technique on sputum samples obtained from a prospective cohort of 70 adults with CF and collected clinical data over an 8 year follow-up period. We examined the associations of the ten most abundant obligate anaerobic bacteria present in the sputum with annual rate of FEV1 change. The presence of Porphyromonas pasteri and Prevotella nanceiensis were associated with a greater annual rate of FEV1 change; −52.3 ml yr−1 (95 % CI-87.7;−16.9), –67.9 ml yr−1 (95 % CI-115.6;−20.1), respectively. Similarly, the relative abundance of these live organisms were associated with a greater annual rate of FEV1 decline of −3.7 ml yr−1 (95 % CI: −6.1 to −1.3, P=0.003) and −5.3 ml yr−1 (95 % CI: −8.7 to −1.9, P=0.002) for each log2 increment of abundance, respectively. The presence and relative abundance of certain anaerobes in the sputum of adults with CF are associated with a greater rate of long-term lung function decline. The pathogenicity of anaerobic bacteria in the CF airways should be confirmed with further longitudinal prospective studies with a larger cohort of participants.
- 3 February 2022
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 71 (2) , 001481
Open AccessPorphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis
Although anaerobic bacteria exist in abundance in cystic fibrosis (CF) airways, their role in disease progression is poorly understood. We hypothesized that the presence and relative abundance of the most prevalent, live, anaerobic bacteria in sputum of adults with CF were associated with adverse clinical outcomes. This is the first study to prospectively investigate viable anaerobic bacteria present in the sputum microbiota and their relationship with long-term outcomes in adults with CF. We performed 16S rRNA analysis using a viability quantitative PCR technique on sputum samples obtained from a prospective cohort of 70 adults with CF and collected clinical data over an 8 year follow-up period. We examined the associations of the ten most abundant obligate anaerobic bacteria present in the sputum with annual rate of FEV1 change. The presence of Porphyromonas pasteri and Prevotella nanceiensis were associated with a greater annual rate of FEV1 change; −52.3 ml yr−1 (95 % CI-87.7;−16.9), –67.9 ml yr−1 (95 % CI-115.6;−20.1), respectively. Similarly, the relative abundance of these live organisms were associated with a greater annual rate of FEV1 decline of −3.7 ml yr−1 (95 % CI: −6.1 to −1.3, P=0.003) and −5.3 ml yr−1 (95 % CI: −8.7 to −1.9, P=0.002) for each log2 increment of abundance, respectively. The presence and relative abundance of certain anaerobes in the sputum of adults with CF are associated with a greater rate of long-term lung function decline. The pathogenicity of anaerobic bacteria in the CF airways should be confirmed with further longitudinal prospective studies with a larger cohort of participants.
- 16 December 2021
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 35 (5) , 757-764
Perception, experience and relationship with food and eating in adults with cystic fibrosis
Background: Cystic fibrosis (CF) is a multisystem disorder that primarily affects the respiratory and gastrointestinal systems. Dietetic therapy is a prominent aspect of CF management, with patients receiving nutritional surveillance and advice throughout their lifetime. The present study aimed to explore the perception, experience and relationship with food and eating in adults with CF.Methods: Semi‐structured telephone interviews were conducted with nine adults with CF. Interviews were audio‐recorded, transcribed verbatim and analysed thematically following a previously described six‐phase procedure.Results: Six themes were identified: ‘Sustained influence of eating experience in childhood’, ‘Eating for health: weight gain to prevent infection’, ‘Balancing health and body image’, ‘I'm different,’ ‘Strategies for managing food intake’ and ‘Support from family, friends and the CF Team’. Participants talked about the range of strategies they employ, with a focus on eating well and choosing high calorie foods being an important part of their health management strategy. This is driven by the belief that a good weight ensures better health and perceiving eating as a treatment.Conclusions: This group felt able to cope well and had developed strategies to manage their dietary needs. Food experience was variable throughout their lifetime, with childhood experience having a sustained effect on adult eating behaviour. Weight gain, body image and dietary health implications are considerable concerns for patients. New CF transmembrane modulator treatments (CFTR modulators) are changing the dietary needs of this population. It is important that these issues are explored during dietetic consultations to identify barriers to dietary change.
- 16 December 2021
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 35 (5) , 757-764
Perception, experience and relationship with food and eating in adults with cystic fibrosis
Background: Cystic fibrosis (CF) is a multisystem disorder that primarily affects the respiratory and gastrointestinal systems. Dietetic therapy is a prominent aspect of CF management, with patients receiving nutritional surveillance and advice throughout their lifetime. The present study aimed to explore the perception, experience and relationship with food and eating in adults with CF.Methods: Semi‐structured telephone interviews were conducted with nine adults with CF. Interviews were audio‐recorded, transcribed verbatim and analysed thematically following a previously described six‐phase procedure.Results: Six themes were identified: ‘Sustained influence of eating experience in childhood’, ‘Eating for health: weight gain to prevent infection’, ‘Balancing health and body image’, ‘I'm different,’ ‘Strategies for managing food intake’ and ‘Support from family, friends and the CF Team’. Participants talked about the range of strategies they employ, with a focus on eating well and choosing high calorie foods being an important part of their health management strategy. This is driven by the belief that a good weight ensures better health and perceiving eating as a treatment.Conclusions: This group felt able to cope well and had developed strategies to manage their dietary needs. Food experience was variable throughout their lifetime, with childhood experience having a sustained effect on adult eating behaviour. Weight gain, body image and dietary health implications are considerable concerns for patients. New CF transmembrane modulator treatments (CFTR modulators) are changing the dietary needs of this population. It is important that these issues are explored during dietetic consultations to identify barriers to dietary change.
- 1 November 2021
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 20, S210-S211
446: Novel detection of specific bacterial quorum-sensing molecules in saliva: Potential noninvasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis
- 1 November 2021
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 20, S210-S211
446: Novel detection of specific bacterial quorum-sensing molecules in saliva: Potential noninvasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis
- Open Access
- 1 October 2021
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 70 (10) , 001420
2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent Pseudomonas aeruginosa burden in adults with cystic fibrosis
Introduction. Pseudomonas aeruginosa produces quorum sensing signalling molecules including 2-alkyl-4-quinolones (AQs), which regulate virulence factor production in the cystic fibrosis (CF) airways. Hypothesis/Gap statement. Culture can lead to condition-dependent artefacts which may limit the potential insights and applications of AQs as minimally-invasive biomarkers of bacterial load. Aim. We aimed to use culture-independent methods to explore the correlations between AQ levels and live P. aeruginosa load in adults with CF. Methodology. Seventy-five sputum samples at clinical stability and 48 paired sputum samples obtained at the beginning and end of IV antibiotics for a pulmonary exacerbation in adults with CF were processed using a viable cell separation technique followed by quantitative P. aeruginosa polymerase chain reaction (qPCR). Live P. aeruginosa qPCR load was compared with the concentrations of three AQs (HHQ, NHQ and HQNO) detected in sputum, plasma and urine. Results. At clinical stability and the beginning of IV antibiotics for pulmonary exacerbation, HHQ, NHQ and HQNO measured in sputum, plasma and urine were consistently positively correlated with live P. aeruginosa qPCR load in sputum, compared to culture. Following systemic antibiotics live P. aeruginosa qPCR load decreased significantly (PP=0.003). Conclusion. In adults with CF, AQ concentrations correlated more strongly with live P. aeruginosa bacterial load measured by qPCR compared to traditional culture. Prospective studies are required to assess the potential of systemic AQs as biomarkers of P. aeruginosa bacterial burden.
- 1 October 2021
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 70 (10) , 001420
Open Access2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent Pseudomonas aeruginosa burden in adults with cystic fibrosis
Introduction. Pseudomonas aeruginosa produces quorum sensing signalling molecules including 2-alkyl-4-quinolones (AQs), which regulate virulence factor production in the cystic fibrosis (CF) airways. Hypothesis/Gap statement. Culture can lead to condition-dependent artefacts which may limit the potential insights and applications of AQs as minimally-invasive biomarkers of bacterial load. Aim. We aimed to use culture-independent methods to explore the correlations between AQ levels and live P. aeruginosa load in adults with CF. Methodology. Seventy-five sputum samples at clinical stability and 48 paired sputum samples obtained at the beginning and end of IV antibiotics for a pulmonary exacerbation in adults with CF were processed using a viable cell separation technique followed by quantitative P. aeruginosa polymerase chain reaction (qPCR). Live P. aeruginosa qPCR load was compared with the concentrations of three AQs (HHQ, NHQ and HQNO) detected in sputum, plasma and urine. Results. At clinical stability and the beginning of IV antibiotics for pulmonary exacerbation, HHQ, NHQ and HQNO measured in sputum, plasma and urine were consistently positively correlated with live P. aeruginosa qPCR load in sputum, compared to culture. Following systemic antibiotics live P. aeruginosa qPCR load decreased significantly (PP=0.003). Conclusion. In adults with CF, AQ concentrations correlated more strongly with live P. aeruginosa bacterial load measured by qPCR compared to traditional culture. Prospective studies are required to assess the potential of systemic AQs as biomarkers of P. aeruginosa bacterial burden.